2026 Global: Medical Exoskeleton Market-Competitive Review (2032) report
Description
The 2026 Global: Medical Exoskeleton Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Ekso Bionics, headquartered in Richmond, United States, pioneers upper and lower limb robotic exoskeletons designed for spinal cord injury rehabilitation and mobility recovery. Its flagship device, the EksoGT, integrates clinical gait therapy with home-use options, reflecting a shift toward outpatient rehab. ReWalk Robotics, based in Yokneam Illit, Israel, develops wearable exoskeleton systems for paraplegia and stroke rehabilitation, expanding gait training access in clinics and residences. Cyberdyne, headquartered in Tsukuba, Japan, introduced the HAL exoskeleton, a pioneering powered suit that interprets bioelectrical signals to assist movement in rehabilitation, research, and industrial safety programs. Parker Hannifin, headquartered in Cleveland, United States, markets the Indego family as modular, user-friendly external devices enabling sit-to-stand transitions and guided gait training across clinical and home settings. Ottobock, based in Duderstadt, Germany, maintains a broad portfolio of assistive devices and exoskeletons, including locomotion platforms, orthopedic supports, and rehab aids tailored to patient needs worldwide.
Hocoma, headquartered near Zurich in Volketswil, Switzerland, is renowned for Lokomat and Armeo rehabilitation robotics, integrating exoskeletal and assistive technologies into physical therapy. SuitX, based in Oakland, United States, develops lighter, modular exoskeletons such as the Phoenix and related platforms designed to reduce muscular strain during industrial tasks and enable therapeutic use in clinics. ExoAtlet, with operations in Moscow, Russia, supplies durable, lower-limb exoskeletons for gait training and functional rehabilitation across hospitals and clinics. Aretech, headquartered in Seoul, South Korea, offers a range of robotic rehabilitation devices including exoskeletons and assistive interfaces, adaptable to hospital settings and outpatient therapy. Bioservo Technologies, based in Stockholm, Sweden, advances soft robotic exoskeletons and assistive gloves such as Ironhand, aimed at improving grip strength and dexterity in occupational therapy and rehabilitation. These companies drive convergence of robotics, sensing, and cloud-based analytics, enabling scalable, patient-centered gait therapy, early mobilization, and safer, efficient rehabilitation pathways globally.
Together, these firms shape the medical exoskeleton market by combining device innovation, software integration, and clinical partnerships that expand mobility for patients with spinal cord injuries, stroke, and degenerative diseases. The geographic diversity, spanning North America, Europe, and Asia, reflects a global shift toward outpatient rehabilitation, home-based therapy, and workplace safety applications, with regulatory pathways and reimbursement policies influencing adoption rates and cross-border commercialization. As advances in materials, control strategies, and sensor fusion mature, collaborations among manufacturers, hospitals, and researchers will determine which platforms achieve durable functional gains, accessible pricing, and sustainable service networks. The evolving ecosystem also emphasizes interoperability, with standards and data-sharing facilitating integrated rehabilitation programs. Regulatory clearance, evidence of clinical efficacy, and patient-reported outcomes will continue to define market leadership as exoskeletons become embedded tools for long-term mobility restoration and independence. Continued investment, collaborative trials, and patient-centric design will sustain growth and broaden access worldwide for patients.
Ekso Bionics, headquartered in Richmond, United States, pioneers upper and lower limb robotic exoskeletons designed for spinal cord injury rehabilitation and mobility recovery. Its flagship device, the EksoGT, integrates clinical gait therapy with home-use options, reflecting a shift toward outpatient rehab. ReWalk Robotics, based in Yokneam Illit, Israel, develops wearable exoskeleton systems for paraplegia and stroke rehabilitation, expanding gait training access in clinics and residences. Cyberdyne, headquartered in Tsukuba, Japan, introduced the HAL exoskeleton, a pioneering powered suit that interprets bioelectrical signals to assist movement in rehabilitation, research, and industrial safety programs. Parker Hannifin, headquartered in Cleveland, United States, markets the Indego family as modular, user-friendly external devices enabling sit-to-stand transitions and guided gait training across clinical and home settings. Ottobock, based in Duderstadt, Germany, maintains a broad portfolio of assistive devices and exoskeletons, including locomotion platforms, orthopedic supports, and rehab aids tailored to patient needs worldwide.
Hocoma, headquartered near Zurich in Volketswil, Switzerland, is renowned for Lokomat and Armeo rehabilitation robotics, integrating exoskeletal and assistive technologies into physical therapy. SuitX, based in Oakland, United States, develops lighter, modular exoskeletons such as the Phoenix and related platforms designed to reduce muscular strain during industrial tasks and enable therapeutic use in clinics. ExoAtlet, with operations in Moscow, Russia, supplies durable, lower-limb exoskeletons for gait training and functional rehabilitation across hospitals and clinics. Aretech, headquartered in Seoul, South Korea, offers a range of robotic rehabilitation devices including exoskeletons and assistive interfaces, adaptable to hospital settings and outpatient therapy. Bioservo Technologies, based in Stockholm, Sweden, advances soft robotic exoskeletons and assistive gloves such as Ironhand, aimed at improving grip strength and dexterity in occupational therapy and rehabilitation. These companies drive convergence of robotics, sensing, and cloud-based analytics, enabling scalable, patient-centered gait therapy, early mobilization, and safer, efficient rehabilitation pathways globally.
Together, these firms shape the medical exoskeleton market by combining device innovation, software integration, and clinical partnerships that expand mobility for patients with spinal cord injuries, stroke, and degenerative diseases. The geographic diversity, spanning North America, Europe, and Asia, reflects a global shift toward outpatient rehabilitation, home-based therapy, and workplace safety applications, with regulatory pathways and reimbursement policies influencing adoption rates and cross-border commercialization. As advances in materials, control strategies, and sensor fusion mature, collaborations among manufacturers, hospitals, and researchers will determine which platforms achieve durable functional gains, accessible pricing, and sustainable service networks. The evolving ecosystem also emphasizes interoperability, with standards and data-sharing facilitating integrated rehabilitation programs. Regulatory clearance, evidence of clinical efficacy, and patient-reported outcomes will continue to define market leadership as exoskeletons become embedded tools for long-term mobility restoration and independence. Continued investment, collaborative trials, and patient-centric design will sustain growth and broaden access worldwide for patients.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
